Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03603964 |
| Consolidated Lead Sponsor | Astex Pharmaceuticals |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 35 participants (ACTUAL) |
| Registered Start Date | 2018-07-18 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Roswell Park Comprehensive Cancer Center | Buffalo, NY | Open Hospital Dossier -> |
| Duke University Medical Center | Durham, NC | Open Hospital Dossier -> |
| Ohio State University Comprehensive Cancer Center | Columbus, OH | Open Hospital Dossier -> |
| Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico | Milan, Italy | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.